45 research outputs found

    An evaluation of indirubin analogues as phosphorylase kinase inhibitors

    Get PDF
    Phosphorylase kinase (PhK) has been linked with a number of conditions such as glycogen storage diseases, psoriasis, type 2 diabetes and more recently, cancer (Camus S. et al., Oncogene 2012, 31, 4333). However, with few reported structural studies on PhK inhibitors, this hinders a structure based drug design approach. In this study, the inhibitory potential of 38 indirubin analogues have been investigated. 11 of these ligands had IC50 values in the range 0.170 – 0.360 µM, with indirubin-3’-acetoxime (1c) the most potent. 7-bromoindirubin-3’-oxime (13b), an antitumor compound which induces caspase-independent cell-death (Ribas J. et al., Oncogene, 2006, 25, 6304) is revealed as a specific inhibitor of PhK (IC50 = 1.8 µM). Binding assay experiments performed using both PhK-holo and PhK-γtrnc confirmed the inhibitory effects to arise from binding at the kinase domain (γ subunit). High level computations using QM/MM-PBSA binding free energy calculations were in good agreement with experimental binding data, as determined using statistical analysis, and support binding at the ATP-binding site. The value of a QM description for the binding of halogenated ligands exhibiting -hole effects is highlighted. A new statistical metric, the ‘sum of the modified logarithm of ranks’ (SMLR), has been defined which measures performance of a model for both the “early recognition” (ranking earlier/higher) of active compounds and their relative ordering by potency. Through a detailed structure activity relationship analysis considering other kinases (CDK2, CDK5 and GSK-3α/β), 6’(Z) and 7(L) indirubin substitutions have been identified to achieve selective PhK inhibition. The key PhK binding site residues involved can also be targeted using other ligand scaffolds in future work

    Glycogen phosphorylase as a molecular target for type 2 diabetes therapy

    No full text
    Journal URL: http://www.bentham.org/cpps

    Effect of Polycarboxylates on Phosphorylase-B

    No full text
    Journal URL: http://www.sciencedirect.com/science/journal/0006291

    Unidentified Activator of Phosphorylase-B

    No full text
    Journal URL: http://www.sciencedirect.com/science/journal/0968000

    Sulfate Activates Phosphorylase-B by Binding to the Ser (P) Site

    No full text
    Journal URL: http://www.sciencedirect.com/science/journal/0167483

    Crystallization of Pig Skeletal Phosphorylase-B - Purification, Physical and Catalytic Characterization

    No full text
    Journal URL: http://www.sciencedirect.com/science/journal/0167483

    Structural basis of the synergistic inhibition of glycogen phosphorylase a by caffeine and a potential antidiabetic drug

    No full text
    Journal URL: http://www.sciencedirect.com/science/journal/0003986

    Interaction of Aliphatic-Amines with Glycogen-Phosphorylase

    No full text
    Journal URL: http://jb.oxfordjournals.org
    corecore